Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate

被引：0
|
作者：
Seto, Wai-Kay [2 ]
Asahina, Yasuhiro [3 ]
Peng, Cheng-Yuan [4 ]
Stanciu, Carol [5 ]
Abdurakhmanov, Djamal [6 ]
Flaherty, John F. [1 ]
Kim, Kyungpil [1 ]
Gaggar, Anuj [1 ]
Subramanian, Mani [1 ]
Tabak, Fehmi [7 ]
Nguyen, Tuan T. [8 ]
Chan, Henry Lik-Yuen [9 ]
机构：
[1] Gilead Sci, Foster City, CA USA
[2] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan
[4] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
[5] Univ Med & Pharm Gr T Popa, Inst Gastroenterol & Hepatol, Iasi, Romania
[6] Univ Clin Hosp 1, Moscow, Russia
[7] Istanbul Univ, Cerrahpassa Tip Fak Hastanesi, Infect Dis, Istanbul, Turkey
[8] Res & Educ Inc, San Diego, CA USA
[9] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
67
引用
收藏
页码：35A / 35A
页数：1
相关论文
共 50 条
  • [31] Bone mineral density changes in young African women on tenofovir disoproxil fumarate antiretroviral therapy and non-hormonal contraception
    Matovu, F. K.
    Kiwanuka, N.
    Nabwana, M.
    Isingel, E.
    Fowler, M. G.
    Nolan, M. L.
    Musoke, P.
    Pettifor, J. M.
    Beksinska, M.
    Brown, T. T.
    HIV MEDICINE, 2019, 20 : 143 - 144
  • [32] Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients-author's reply
    Papatheodoridis, George V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 918 - 919
  • [33] Population Pharmacokinetics of Tenofovir (TFV) and Tenofovir Diphosphate (TFVdp) in the Blood, Semen, and Mononuclear Cells of HIV-Negative and Positive Men Receiving Tenofovir Disoproxil Fumarate (TDF) or Tenofovir Alafenamide (TAF)
    Greene, Stephen A.
    Chen, Jingxian
    Prince, Heather
    Maas, Brian
    Maffuid, Kaitlyn
    Garrett, Katy
    Sykes, Craig
    Schauer, Amanda
    Gay, Cynthia L.
    Kashuba, Angela D. M.
    Cohen, Myron S.
    Dumond, Julie B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S113 - S113
  • [34] Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
    Lin, Shenglong
    Huang, Wanlong
    Liao, Ziyuan
    Ma, Huaxi
    Wu, Wenjun
    Lin, Minghua
    Huang, Defu
    Gao, Haibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
    Ping Zhang
    Qingli Liu
    Mei Yuan
    Lina Wang
    Infectious Agents and Cancer, 13
  • [36] Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB- patients with compensated cirrhosis
    Zhang, Ping
    Liu, Qingli
    Yuan, Mei
    Wang, Lina
    INFECTIOUS AGENTS AND CANCER, 2018, 13
  • [37] Tenofovir disoproxil fumarateDecreased bone mineral density in paediatric patients: 5 case reports
    Reactions Weekly, 2008, 1203 (1) : 36 - 36
  • [38] Assessing bone mineral density in children and adolescents living with HIV and on treatment with tenofovir disoproxil fumarate: a systematic review
    de Gusmao, Maria Brennda Ferreira
    de Oliveira, Vinicius Vital
    Santos, Natalia Maria da Silva
    Melo, Luciana Costa
    REVISTA PAULISTA DE PEDIATRIA, 2024, 42
  • [39] ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) RISK PROFILE OF TENOFOVIR ALAFENAMIDE (TAF) VERSUS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HBV (CHB) PATIENTS UNDER ANTIVIRAL THERAPY FOR 2 YEARS
    Fung, Scott K.
    Ahn, Sang Hoon
    Chen, Chi-Yi
    Elkhashab, Magdy
    Hann, Hie-Won L.
    Jablkowski, Maciej S.
    Kim, Yoon Jun
    Yurdaydin, Cihan
    Peng, Cheng-Yuan
    Tuan Nguyen
    Yatsuhashi, Hiroshi
    Inokuma, Tetsuro
    Tan, Susanna K.
    Flaherty, John F.
    Wang, Hongyuan
    Osinusi, Anu O.
    Temme, Lauren
    Lum, Ernie
    Lam, Kelly
    Abdurakhmanov, Dzhamal
    Lim, Young-Suk
    Buti, Maria
    HEPATOLOGY, 2021, 74 : 470A - 471A
  • [40] Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV
    Hoy, Jennifer F.
    Richardson, Robyn
    Ebeling, Peter R.
    Rojas, Jhon
    Pocock, Nicholas
    Kerr, Stephen J.
    Martinez, Esteban
    Carr, Andrew
    AIDS, 2018, 32 (14) : 1967 - 1975
12345